The ISET® technology has been developed by a team of physicians and scientists from the company Rarecells Diagnostics, spinoff of the University Paris Descartes, AP-HP (Assistance Publique-Hôpitaux de Paris) and INSERM (Institut National de la Santé et de la Recherche Médicale) working to improve the life of cancer patients.
Behind the ISET® technology is a team of dynamic people working to provide the best diagnostic method for cancer patients, helping to save lives through early diagnosis of invasive cancers, the only cancers who threaten patients’ life.
As oncologists and scientists, the ISET® team members work together to put the best diagnostic tools in the hands of oncologists for a better treatment of patients; and in the hands of other scientists for further research in the field of cancer invasion.
The ISET® method is already used for Research Use Only by scientists, researchers and doctors in more than 14 countries.
The ISET® team is committed to making the technology available for patients everywhere and to provide a diagnostic tool improving the span and quality of life for cancer patients. The ISET® team believes in and works for medical, ethical and scientific excellence and uses scientific innovation to help cancer patients fight for a better life.